EPRX Hedge Fund Ownership (Q2 2026)

Eupraxia Pharmaceuticals Inc (EPRX)

67 + Investors. Track Smart Money conviction in EPRX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — EPRX

Based on 67 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 8 quarters in a row

last 6Q

For 8 consecutive quarters, more hedge funds added EPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

67 hedge funds hold EPRX right now — the highest count in 2.2 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +379% more funds vs a year ago

fund count last 6Q

+53 new funds entered over the past year (+379% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 65% buying

40 buying22 selling

Last quarter: 40 funds were net buyers (19 opened a brand new position + 21 added to an existing one). Only 22 were sellers (17 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~19 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 15 → 14 → 21 → 19. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 67% entered in last year

■ 6% conviction (2yr+) ■ 27% medium ■ 67% new

Only 4 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

📈

Growing discovery — still being found

3 → 15 → 14 → 21 → 19 new funds/Q

New funds entering each quarter: 15 → 14 → 21 → 19. A growing number of institutions are discovering EPRX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 81% of holders entered in last year

■ 0% veterans ■ 19% 1-2yr ■ 81% new

Of 67 current holders: 54 (81%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds

14 of 67 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

6.7

out of 10

Moderate Exit Risk

Exit risk score 6.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	67	53	26.42%
13F Shares	25M	22M	11.37%
Total Value	$139M	$131M	6.37%
New Positions	19	21	-2
Increased Positions	20	19	+1
Closed Positions	5	3	+2
Reduced Positions	18	6	+12
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

26.42%

13F Shares

25M

22M

11.37%

Total Value

$139M

$131M

6.37%

New Positions

-2

Increased Positions

Closed Positions

Reduced Positions

+12

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

67 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EPRX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 EPRX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Great Point Partners LLC	1.50%	1,200,000	$7.9M
2	Ally Bridge Group (NY) LLC	1.47%	252,175	$1.7M
3	Velan Capital Investment Management LP	1.42%	352,000	$2.3M
4	Vivo Capital, LLC	0.81%	1,350,000	$8.9M
5	PFM Health Sciences, LP	0.69%	1,210,661	$8.0M
6	Seven Fleet Capital Management LP	0.67%	610,785	$4.0M
7	Ikarian Capital, LLC	0.58%	809,741	$5.4M
8	Affinity Asset Advisors, LLC	0.49%	1,650,000	$10.9M
9	Aisling Capital Management LP	0.46%	325,000	$2.1M
10	DAFNA Capital Management LLC	0.28%	225,600	$1.5M
11	Redmile Group, LLC	0.27%	611,400	$4.0M
12	Dv Equities, LLC	0.26%	276,000	$1.8M
13	Stonepine Capital Management, LLC	0.13%	43,491	$287K
14	Delaney Capital Management Ltd.	0.12%	117,200	$768K
15	Annis Gardner Whiting Capital Advisors, LLC	0.06%	60,000	$397K
16	SummitTX Capital, L.P.	0.05%	318,784	$2.1M
17	Rubric Capital Management LP	0.05%	867,424	$5.7M
18	Orbimed Advisors LLC	0.03%	269,000	$1.8M
19	Scotia Capital INC.	0.03%	1,343,726	$8.8M
20	Boothbay Fund Management, LLC	0.02%	212,653	$1.4M
21	Picton Mahoney Asset Management	0.02%	360,878	$2.4M
22	Woodline Partners LP	0.02%	746,864	$4.9M
23	Axq Capital, LP	0.02%	21,150	$140K
24	Lynx1 Capital Management LP	0.01%	10,000	$66K
25	Balyasny Asset Management L.P.	0.01%	1,350,015	$8.9M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Eupraxia Pharmaceuticals Inc (EPRX)

What does the Smart Money Trend signal show for EPRX?

Buying streak — 8 quarters in a row: For 8 consecutive quarters, more hedge funds added EPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EPRX?

More buyers than sellers — 65% buying: Last quarter: 40 funds were net buyers (19 opened a brand new position + 21 added to an existing one). Only 22 were sellers (17 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for EPRX holders?

Smaller funds dominant — 15% AUM from top-100: 14 of 67 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held EPRX?

Mostly new holders — 67% entered in last year: Only 4 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Eupraxia Pharmaceuticals Inc (EPRX)

Smart Money Signals — EPRX

Buying streak — 8 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +379% more funds vs a year ago

More buyers than sellers — 65% buying

Steady new buyers — ~19 new funds per quarter

Mostly new holders — 67% entered in last year

Growing discovery — still being found

Early stage — 81% of holders entered in last year

Smaller funds dominant — 15% AUM from top-100

Institutional Sentiment Summary — EPRX

Hedge Fund Ownership: EPRX

Market Analysis: EPRX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: EPRX

Hedge Fund Positioning: EPRX

Statistics: EPRX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Eupraxia Pharmaceuticals Inc (EPRX)

Welcome to 13Foresight!